SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Block listing update

8 Oct 2019 10:00

RNS Number : 1338P
Porvair PLC
08 October 2019
 

8 October 2019

 

Porvair plc

("Porvair" or the "Group")

 

Block listing update

 

Porvair, the specialist filtration and environmental technologies group, announces that an application has been made to the Financial Conduct Authority ("FCA") and London Stock Exchange ("LSE") in order to increase an existing block listing of ordinary shares of 2 pence per share ("Ordinary Shares") used to satisfy the issue of shares pursuant to exercises of options under the Porvair plc SAYE Share Option Plan 2014 ("SAYE Plan").

 

Application has been made for the admission of 510,269 new Ordinary Shares to the premium listing segment of the Official List of the FCA and to trading on the main market of the LSE (together "Admission"). New Ordinary Shares issued under the block listing will rank pari passu in all respect with the existing Ordinary Shares of the Company. It is expected that Admission will become effective on 10 October 2019.

 

In addition, the Company currently has 21,925 new Ordinary Shares admitted (but not yet issued) under an existing block listing that relate to the Porvair Long Term Share Plan 2008 (the "LTSP"). All share issues expected to be required in order to satisfy the exercise of options under the LTSP have been made and, as a result, the associated LTSP block listing will be cancelled. The Company made 151,375 allotments under the LTSP since the last block listing return. The block listing return, as at 7 October 2019 is set out below.

 

The Company's issued share capital will not change as a result of the changes to the block listings set out above.

 

Total Voting Rights

The Company's issued share capital consists of 45,843,599 Ordinary Shares with voting rights. Therefore, the total number of voting rights in the Company will be 45,843,599. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the disclosure guidance issued by the FCA and the transparency rules made by the FCA under section 89A(1) of the Financial Services and Markets Act 2000, as amended.

 

For more information, contact:

 

Porvair plc

 

Ben Stocks, Chief Executive

01553 765 500

Chris Tyler, Group Finance Director

01553 765 500

 

 

Buchanan

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

Name of applicant:

Porvair plc

Name of scheme:

Porvair Long Term Share Plan 2008

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

173,300

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(151,375)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

21,925

 

Name of applicant:

Porvair plc

Name of scheme:

Porvair plc SAYE Share Option Plan 2014

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

129,561

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

510,269

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(51,049)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

588,781

 

 

Name of contact:

Chris Tyler (Group Finance Director)

Telephone number of contact:

01553 765 500

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSUWVWRKNARRRA
Date   Source Headline
27th Mar 20257:00 amRNSGrant of SAYE Options
18th Mar 20257:40 amRNSHolding(s) in Company
17th Mar 20253:30 pmRNSHolding(s) in Company
14th Mar 20257:00 amRNSNotice of Annual General Meeting; Accounts posting
4th Mar 20253:00 pmRNSHolding(s) in Company
12th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSFull Year Results
12th Dec 20241:00 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTrading update and notice of results
2nd Dec 20243:01 pmRNSTotal Voting Rights
2nd Dec 20243:00 pmRNSDirector/PDMR Shareholding
25th Nov 20244:37 pmRNSShareholder Communications
28th Oct 20247:00 amRNSBoard appointment
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSAppointment of Chief Executive Officer
2nd Sep 20245:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20245:00 pmRNSTotal Voting Rights
31st Jul 202410:45 amRNSTotal Voting Rights
31st Jul 202410:30 amRNSBlock listing Interim Review
29th Jul 20246:15 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSInterim Results
27th Jun 20242:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.